These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17285459)

  • 1. New Agents in Clinical Oncology. 24 November 2006, London, UK.
    Martin S
    IDrugs; 2007 Feb; 10(2):99-101. PubMed ID: 17285459
    [No Abstract]   [Full Text] [Related]  

  • 2. [131I]MIBG and topotecan: a rationale for combination therapy for neuroblastoma.
    McCluskey AG; Boyd M; Gaze MN; Mairs RJ
    Cancer Lett; 2005 Oct; 228(1-2):221-7. PubMed ID: 15935554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [131I]meta-iodobenzylguanidine and topotecan combination treatment of tumors expressing the noradrenaline transporter.
    McCluskey AG; Boyd M; Ross SC; Cosimo E; Clark AM; Angerson WJ; Gaze MN; Mairs RJ
    Clin Cancer Res; 2005 Nov; 11(21):7929-37. PubMed ID: 16278418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenesis drugs target specific cancers, mechanisms.
    Randal J
    J Natl Cancer Inst; 2000 Apr; 92(7):520-2. PubMed ID: 10749899
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-angiogenesis: the challenges ahead.
    Mariani SM
    MedGenMed; 2003 Apr; 5(2):22. PubMed ID: 14603121
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of poly(ADP-ribose) polymerase in cancer.
    Plummer ER
    Curr Opin Pharmacol; 2006 Aug; 6(4):364-8. PubMed ID: 16753340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disrupting tumour blood vessels.
    Tozer GM; Kanthou C; Baguley BC
    Nat Rev Cancer; 2005 Jun; 5(6):423-35. PubMed ID: 15928673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 25 years of oncology.
    Spittle MF
    Br J Hosp Med; 1991 Oct; 46(4):249, 251. PubMed ID: 1954491
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic enhancement of radionuclide cancer therapy.
    Wheldon TE; Mairs RJ; Boyd M
    Lancet; 1999 Dec; 354(9194):1999-2000. PubMed ID: 10622325
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA topoisomerase I-targeting drugs as radiation sensitizers.
    Chen AY; Choy H; Rothenberg ML
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):39-46. PubMed ID: 10550825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly adenosine diphosphate-ribose polymerase inhibitors and heat shock protein 90 inhibitors.
    Riely GJ
    J Thorac Oncol; 2011 Nov; 6(11 Suppl 4):S1803-4. PubMed ID: 22005537
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer: one step at a time.
    Mooney D
    Nature; 2005 Jul; 436(7050):468-9. PubMed ID: 16049458
    [No Abstract]   [Full Text] [Related]  

  • 13. American Association of Cancer Research--95th annual meeting. Highlights. 27-31 March, 2004, Orlando, FL, USA.
    Kibble A; Davies J
    IDrugs; 2004 May; 7(5):416-9. PubMed ID: 15154096
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential response of tumor cells and normal fibroblasts to fractionated combined treatment with topotecan and ionizing radiation.
    Ohneseit PA; Wildemann A; Herskind C; Bamberg M; Rodemann HP
    Int J Radiat Biol; 2002 Feb; 78(2):125-32. PubMed ID: 11779362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical oncology in the 1990s.
    Braverman AS
    Lancet; 1991 Apr; 337(8746):901-2. PubMed ID: 1672980
    [No Abstract]   [Full Text] [Related]  

  • 16. [Topotecan: a new discovery and future prospects].
    Bianco AR
    Tumori; 1999; 85(6 Suppl 1):S1-2. PubMed ID: 10786193
    [No Abstract]   [Full Text] [Related]  

  • 17. [Present and future of therapeutic oncology].
    García G; Beltrán-Ortega A; Díaz-Perches R; de la Garza-Salazar JG; Noriega-Limón J; Jiménez-Zamudio L
    Gac Med Mex; 1984; 120(7-8):281-300. PubMed ID: 6526215
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiation combined with antiangiogenic and antivascular agents.
    O'Reilly MS
    Semin Radiat Oncol; 2006 Jan; 16(1):45-50. PubMed ID: 16378906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerase II inhibitors.
    Martincic D; Hande KR
    Cancer Chemother Biol Response Modif; 2005; 22():101-21. PubMed ID: 16110609
    [No Abstract]   [Full Text] [Related]  

  • 20. DNA topoisomerase I inhibitors.
    Takimoto CH; Kieffer LV; Arbuck SG
    Cancer Chemother Biol Response Modif; 1997; 17():80-113. PubMed ID: 9551210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.